|
| |
GE
Healthcare's IN Cell Analyzer Recognized with 2007 Frost & Sullivan Technology
Innovation Award
Award demonstrates technical superiority of GE’s High Content Analysis
Systems
Buckinghamshire, UK, 20th September 2007 – GE Healthcare announced today that it
has received the 2007 Frost & Sullivan Technology Innovation Award in
recognition of its exceptional success with its IN Cell Analyzer range of
products in the High Content Screening Market. These advanced and easy-to-use
automated microscope systems enhance the productivity of cell-based research by
combining system flexibility with excellent image and data quality.
“GE Healthcare received the highest scores for ‘Innovation Performance’,
attributed to its IN Cell Analyzer systems”, said Jonathan Witonsky, Industry
Analyst at Frost & Sullivan. “We also recognised the Company’s excellence in
best practices to identify researchers’ high content screening needs, in the
development of new instrumentation, software, reagents and strategic technology
enhancements in order to bring innovative products to its customers quickly.
One of the products in the IN Cell Analyser range is the IN Cell Investigator, a
comprehensive analysis software solution that complements the IN Cell Analyzer
instruments. It combines pre-developed application-specific modules suitable for
novice use with the Developer toolbox which enables customers to write their own
analysis routines for unique assays. GE Healthcare has also developed Bio InSite,
a secure technical support system providing a digital connection between GE
Healthcare professionals and customer systems for knowledge sharing and
simplified troubleshooting.
“We are delighted to receive this years’ innovation award from Frost & Sullivan.
As the HCA field continues to grow, this award demonstrates the unique benefits
provided by the IN Cell Analyzer systems and tools.” said Ger Brophy, General
Manager of Advanced Systems in the Life Sciences business unit of GE Healthcare.
“The IN Cell Analyzer enables more complex analysis on a much larger scale,
while providing a flexible future-proof system to meet individual research
laboratory needs. We will continue to be customer-focused in our development and
supply of HCA tools and services to enable scientists to be more productive in
their daily work”.
For more information about Frost & Sullivan’s Best Practices Award, go to
www.awards.frost.com .
-ENDS-
For a high-resolution image of the IN Cell Analyzer system, please contact Dr
Marc Egelhofer at
m.egelhofer@northbankcommunications.com or +44 (0)207 268 3247.
About GE Healthcare:
GE Healthcare provides transformational medical technologies and services
that are shaping a new age of patient care. Our expertise in medical imaging and
information technologies, medical diagnostics, patient monitoring systems,
performance improvement, drug discovery, and biopharmaceutical manufacturing
technologies is helping clinicians around the world re-imagine new ways to
predict, diagnose, inform, treat and monitor disease, so patients can live their
lives to the fullest.
GE Healthcare's broad range of products and services enable healthcare providers
to better diagnose and treat cancer, heart disease, neurological diseases and
other conditions earlier. Our vision for the future is to enable a new "early
health" model of care focused on earlier diagnosis, pre-symptomatic disease
detection and disease prevention. Headquartered in the United Kingdom, GE
Healthcare is a US$17 billion unit of General Electric Company (NYSE: GE).
Worldwide, GE Healthcare employs more than 46,000 people committed to serving
healthcare professionals and their patients in more than 100 countries. For more
information about GE Healthcare, visit our website at
www.gehealthcare.com .
For further information please contact:
Northbank Communications
Lorna Cuddon, Marc Egelhofer, Katie Odgaard
+44 (0)207 268 3002
gehealthcare@northbankcommunications.com
GE Healthcare
Nicola Simpson
+44 (0)1494 542 626
nicola.simpson@ge.com
| |
|
